Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytologic specimens from breast carcinoma: Correlation with histologic sections determinations and diagnostic pitfalls
- 23 March 2004
- journal article
- research article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 30 (4) , 251-256
- https://doi.org/10.1002/dc.20007
Abstract
Although fine‐needle aspiration cytology is a routine procedure for the diagnosis of breast carcinoma, cytologic specimens have rarely been used for evaluation of hormone receptor status and HER2/neu overexpression. In order to compare the biological markers on cytology and on histology, routinely fixed smears of 110 primary breast carcinomas were immunostained for estrogen receptor (ER), progesterone receptor (PgR), and HER2/neu by automated immunostainer and the results were compared with the corresponding histologic sections. ER was expressed in 76 of 110 (69%) cases and PgR was expressed in 51 of 110 (46%). Overexpression of HER2/neu was observed in 30 of 110 (27%) cases. Concordance between cytology and histology was 98% for ER, 95% for PgR, and 100% for HER2/neu. There was no false positive result on smears. Diagnostic pitfalls in determination of hormone receptor status on smears included intratumoral heterogeneity and presence of mucin. Diagn. Cytopathol. 2004;30:251–256.Keywords
This publication has 33 references indexed in Scilit:
- Cytologic evaluation of cyclin D1 expression in primary breast carcinomaCancer, 2001
- Proliferative Activity in Invasive Breast CarcinomaActa Cytologica, 2001
- Estimation of estrogen receptor content in fine‐needle aspirates from breast cancer using the monoclonal antibody 1d5 and microwave oven processing: Correlation with paraffin embedded and frozen sections determinationsDiagnostic Cytopathology, 1995
- p53 protein expression in fine‐needle aspirates of breast cancer: An immunocytochemical assay for identifying high‐grade ductal carcinomasDiagnostic Cytopathology, 1995
- Retrospective c‐erbB‐2 immunostaining in aspiration cytology of breast cancerDiagnostic Cytopathology, 1994
- Diagnostic associations of p53 immunostaining in fine needle aspiration cytology of the breastCytopathology, 1994
- Immunocytochemical localization of estrogen and progesterone receptors in imprint preparations of breast carcinomasCancer, 1992
- Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomasBreast Cancer Research and Treatment, 1990
- PREDICTION OF ENDOCRINE RESPONSE IN BREAST CANCER BY IMMUNOCYTOCHEMICAL DETECTION OF OESTROGEN RECEPTOR IN FINE-NEEDLE ASPIRATESThe Lancet, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987